Product Information
PALIPERIDONE ER 3 MG TABLET is a generic product labeled by American Health Packaging, priced at $0.9719 per EA under NDC 60687045901. Its NADAC has been published 347 times since Feb 12, 2020.
FDA first approved this application on Apr 6, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
3 mg/1
Manufacturer
American Health PackagingNDC
60687045901
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
PALIPERIDONEApproval Type
Generic (ANDA)
FDA Application
ANDA205618FDA Approved
4/6/2018
TE Code
AB
On Market Since
1/15/2020
Pharmacological Classes
Price Statistics
The NADAC for PALIPERIDONE ER 3 MG TABLET has been published 347 times since Feb 12, 2020, and over the history we have for it it has declined 90.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.9719 per EA |
|---|---|
| All-time high | $9.7389 (Feb 12, 2020) |
| All-time low | $0.9120 (Aug 19, 2026) |
| 52-week high | $1.2652 |
| 52-week low | $0.9120 |
| Median price | $2.0481 |
| Average price | $3.6212 |
| Largest weekly change | +62.1% (Jul 21, 2021) |
| Weeks tracked | 347 |
| Tracking since | Feb 12, 2020 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
American Health Packaging manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Paliperidone market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Atypical Antipsychotic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PALIPERIDONE ER 3 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PALIPERIDONE ER 3 MG TABLET, manufactured by American Health Packaging, is $0.9719 per EA (NDC 60687045901), effective Sep 30, 2026.
How has the price of PALIPERIDONE ER 3 MG TABLET changed over time?
Over the history we have for it, the NADAC for PALIPERIDONE ER 3 MG TABLET has declined 90.0%. It has been tracked across 347 weekly CMS publications since Feb 12, 2020.
What are the highest and lowest recorded NADAC prices for PALIPERIDONE ER 3 MG TABLET?
Since Feb 12, 2020, the NADAC for PALIPERIDONE ER 3 MG TABLET has ranged from a low of $0.9120 (Aug 19, 2026) to a high of $9.7389 (Feb 12, 2020), with a median of $2.0481 per EA.
Are there cheaper alternatives to PALIPERIDONE ER 3 MG TABLET?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as PALIPERIDONE ER 3 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures PALIPERIDONE ER 3 MG TABLET?
PALIPERIDONE ER 3 MG TABLET (NDC 60687045901) is labeled by American Health Packaging, and CMS classifies it as a generic product.